Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from PDS Biotechnology

2 Biopharmaceutical Stocks Focused on Cancer That Wall Street Predicts Will More Than Double

Analysts are uber bullish on Actuate Therapeutics and PDS Biotechnology stocks for the next 12 months. Here’s why.

12 Health Care Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Thursday's Intraday Session

12 Health Care Stocks Moving In Thursday's Intraday Session

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

12 Health Care Stocks Moving In Tuesday's Intraday Session

Recap Of Thursday's Biotech Catalysts - End Of the Day Summary

The European Commission (EC) has approved AstraZeneca (NASDAQ: AZN) and Merck’s (NYSE: MRK) LYNPARZA as monotherapy or in combination with endocrine therapy for the adjuvant treatment of adult patients with germline B

PDS Biotechnology Gains On FDA Fast Track Designation For Lead Candidate

12 Health Care Stocks Moving In Tuesday's Intraday Session

inkl

Read news from The Economist, FT, and more,
with one subscription

Recap: PDS Biotechnology Q1 Earnings

Recap: PDS Biotechnology Q1 Earnings

PDS Biotechnology (NASDAQ:PDSB) reported its Q1 earnings results on Wednesday, May 11, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

PDS Biotechnology: Q4 Earnings Insights

PDS Biotechnology: Q4 Earnings Insights

PDS Biotechnology (NASDAQ:PDSB) reported its Q4 earnings results on Thursday, March 31, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Earnings Outlook For PDS Biotechnology

Earnings Outlook For PDS Biotechnology

PDS Biotechnology (NASDAQ:PDSB) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that PDS Biotechnology will report an earnings per share (EPS) of $-0.24.

PDS Biotechnology Earnings Conference Call Is Coming Up, Here's What You Need To Know

PDS Biotechnology Earnings Conference Call Is Coming Up, Here's What You Need To Know

PDS Biotechnology (NASDAQ:PDSB) will host a conference call at 08:00 AM ET on March 31, 2022, to discuss Q4 2021 earnings results.

Earnings Preview For PDS Biotechnology

Earnings Preview For PDS Biotechnology

PDS Biotechnology (NASDAQ:PDSB) is set to give its latest quarterly earnings report on Wednesday, 2022-03-23. Here's what investors need to know before the announcement. Analysts estimate that PDS Biotechnology will report an earnings per share (EPS) of $-0.24.

Organisations

US Food and Drug Administration

Cassava Sciences

Rigel Pharmaceuticals

PDS Biotechnology

Reshape Lifesciences

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play